Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Feasibility and Safety of Intranasally Administered Breast Milk in HIE — Stella

Home/Hypoxic Ischaemic Encephalopathy (HIE)/Feasibility and Safety of Intranasally Administered Breast Milk in HIE

View on ClinicalTrials.gov

Recruiting

Back to Hypoxic Ischaemic Encephalopathy (HIE) trials

Feasibility and Safety of Intranasally Administered Breast Milk in HIE

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

Hungary

Division of Neonatology, Pediatric Center, Semmelweis University, Budapest, Hungary, Budapest

Key details

Phase

Very early testing

Sponsor

Semmelweis University

Enrollment target

~10 participants

Started

November 2024

Primary completion

September 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.